Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Yore

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Reviews. Cancer|April 21, 2007
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerKaren T Liby, Mark M Yore, Michael B Sporn
The Journal of Biological Chemistry|January 6, 2005
Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acidKristina A White, Mark M Yore, Dexin Deng, et al.
Molecular Cancer Therapeutics|December 7, 2006
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase betaMark M Yore, Karen T Liby, Tadashi Honda, et al.
Plos One|August 6, 2011
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTORMark M Yore, Arminja N Kettenbach, Michael B Sporn, et al.
The Journal of Biological Chemistry|January 21, 2006
Smoothened regulates activator and repressor functions of Hedgehog signaling via two distinct mechanismsStacey K Ogden, David J Casso, Manuel Ascano, et al.
Journal of Natural Products|February 12, 2011
New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stressMichael B Sporn, Karen T Liby, Mark M Yore, et al.
Cell Metabolism|March 11, 2014
RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistancePedro M Moraes-Vieira, Mark M Yore, Peter M Dwyer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in miceKaren Liby, Renee Risingsong, Darlene B Royce, et al.
The Journal of Biological Chemistry|September 25, 2003
Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140Kristina A White, Mark M Yore, Shannon L Warburton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2020
Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4Pedro M Moraes-Vieira, Mark M Yore, Alexandra Sontheimer-Phelps, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|April 21, 2007
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerKaren T Liby, Mark M Yore, Michael B Sporn
The Journal of Biological Chemistry|January 6, 2005
Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acidKristina A White, Mark M Yore, Dexin Deng, et al.
Molecular Cancer Therapeutics|December 7, 2006
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase betaMark M Yore, Karen T Liby, Tadashi Honda, et al.
Plos One|August 6, 2011
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTORMark M Yore, Arminja N Kettenbach, Michael B Sporn, et al.
The Journal of Biological Chemistry|January 21, 2006
Smoothened regulates activator and repressor functions of Hedgehog signaling via two distinct mechanismsStacey K Ogden, David J Casso, Manuel Ascano, et al.
Journal of Natural Products|February 12, 2011
New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stressMichael B Sporn, Karen T Liby, Mark M Yore, et al.
Cell Metabolism|March 11, 2014
RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistancePedro M Moraes-Vieira, Mark M Yore, Peter M Dwyer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in miceKaren Liby, Renee Risingsong, Darlene B Royce, et al.
The Journal of Biological Chemistry|September 25, 2003
Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140Kristina A White, Mark M Yore, Shannon L Warburton, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2020
Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4Pedro M Moraes-Vieira, Mark M Yore, Alexandra Sontheimer-Phelps, et al.
Pageof 2